ORIGINAL ARTICLE

Melasma characteristic in hormonal contraceptive acceptors at Kelurahan Mangga Kecamatan Medan Tuntungan, Medan-Indonesia

Ilen Mahdalena , Nelva K Jusuf, Imam B Putra

Ilen Mahdalena
Faculty of Medicine University of Sumatera Utara, Indonesia. Email: ilen.mahdalena@gmail.com

Nelva K Jusuf
Department of Dermatology and Venereology Faculty of Medicine University of Sumatera Utara, Indonesia

Imam B Putra
Department of Dermatology and Venereology Faculty of Medicine University of Sumatera Utara, Indonesia
Online First: October 03, 2018 | Cite this Article
Mahdalena, I., Jusuf, N., Putra, I. 2018. Melasma characteristic in hormonal contraceptive acceptors at Kelurahan Mangga Kecamatan Medan Tuntungan, Medan-Indonesia. Bali Medical Journal 7(3). DOI:10.15562/bmj.v7i3.1000


Background: Melasma is one of the most common skin problems in dermatology. Areas often exposed to ultraviolet, especially the face as a predilection of its disorder. The etiology of melasma remains unknown. There are several risk factors considered to play a role in the pathogenesis of melasma, one of them is the hormone, especially those contained in hormonal contraceptives.

Aim: To know the characteristic of melasma related hormonal contraceptive acceptors in Kelurahan Mangga Kecamatan Medan Tuntungan, Medan.

Methods: This was a cross-sectional descriptive study which involved 83 subjects with hormonal contraceptive acceptors in Kelurahan Mangga Kecamatan Medan Tuntungan, Medan. Diagnosis of melasma was made based on history, clinical features and by Wood’s lamp examination. The data obtained is processed and presented in tabulation form.

Results: In this study, the proportion of melasma in hormonal contraceptive acceptors was 17 subjects (20.5%). The proportion of melasma in oral contraceptive acceptors was 6 subjects (26.1%), injection of 7 subjects (19.4%), implant 4 subjects (16.7%). Based on the hormonal contraceptive content, the proportion of melasma contains estrogen and progesterone was 11 subjects (23.4%) and progesterone alone 6 subjects (16.7%). Based on duration of hormonal contraceptive use melasma was found during 6-12 months in 2 subjects (11.7%), 13-24 months in 1 subjects (5,9%), 24-36 months in 4 subject (23,5%), >36 months in 10 subject (58,8%). Based on the type of clinical pattern that is centrofacial type in 9 subjects (52,9%), malar in 8 subjects (47,1%). Based on Wood’s lamp is epidermal type in 16 subjects (94.1%), dermal type in 1 subject (5,9%).

Conclusions: In hormonal contraceptive acceptors was obtained proportion of melasma 20,5% with oral contraception by 26.1%, 19.4% injection and 16.7% implant. Proportion of melasma contains estrogen and progesterone was 23.4%. Duration of hormonal contraceptive use, melasma was found at most more than 36 months in 58,8%. The most commonly found clinical pattern that is centrofacial type in 52,9% and based on Wood’s lamp is epidermal type in 94.1%.

References

Handel AC, Miot LDB, Miot HA. Melasma: a clinical and epidemiological review. An Bras Dermatol. 2014;89(5):771-82. doi: 10.1590/abd1806-4841.20143063

Handel AC, Lima PB, Tonolli VM, Miot LDB, Miot HA. Risk factors for facial melasma in women: a case-control study. British Journal of Dermatology 2014; 171: 588-94

Lee AY. An updated review of melasma pathogenesis. Dermatology Sinica. 2014; 233-39. doi: 10.1016/j.dsi.2014.09.006

Soepardiman L. Kelainan pigmen. Dalam: Djuanda A, Hamzah M, Aisah S, editor. Ilmu Penyakit Kulit Dan Kelamin. Edisi ke-6. Jakarta: Balai Penerbit FKUI; 2013: 289-300.

Perez BA, Munoz PMA, Camacho E.Management of facial hyperpigmentation. AmJ Clin Dermatol. 2000; 1(5): 261-8

Mahmood K, Nadeem M, Aman S, Hameed A, Kazmi AH. Role of estrogen, progesterone and prolactin in the etiopathogenesis of melasma in females. Journal of Pakistan Association of Dermatologists 2011; 21 (4): 241-247.

Jadotte YT, Schwartz RA. Melasma: insights and perspectives. Acta Dermatovenerol Croat. 2010; 18(2): 124-29

Achwal I, Teri EM, Huber D. Management of Common Contraceptive Problems: A Problem Solving Reference Manual for Service Providers in Africa. 2000; 3-11

Ortonne JP, Arellano I, Berneburg M, Cestari T, Chan H, Grimes P, et al. A global survey of the role of ultraviolet radiation and hormonal influences in the development of melasma. J Eur Acad Dermatol Venereol 2009;23:1254 62

Suhartono D. Prevalensi dan beberapa karakteristik penderita melasma pada pemakai kontrasepsi hormonal [thesis]. Semarang : Universitas Diponegoro; 2001.

Guinot C, Cheffai S, Latreille J, Dhaoui MA, Youssef S, Jaber K, et al. Aggravating factors for melasma: a prospective study in 197 Tunisian patients. Journal European Academy of Dermatology and Venereology. 2010; 24, 1060–69. doi: 10.1111/j.1468-3083.2010.03592.

Tamega Ade A, Miot LD, Bonfietti C, Gige TC, Marques ME, Miot HA. Clinical patterns and epidemiological characteristics of facial melasma in Brazilian women. Journal European Academy of Dermatology and Venereology. 2013;27:151-56. doi: 10.1111/j.1468-3083.2011.04430.

Achar, A., and Rathi, S.K. Melasma: a clinico-epidemiological study of 312 cases. Indian J. Dermatol. 2011; 56, 380–82.

Im S, Lee ES, Kim W, On W, Kim J, Lee M, et al. Donor specific response of estrogen and progesterone on cultured human melanocytes. J Korean Med Sci. 2002; 17: 58-64.

Jang YH, Lee JY, Kang HY, Lee ES, Kim YC. Oestrogen and progesterone receptor expression in melasma: an immunohistochemical analysis. Journal of the European Academy of Dermatology and Venereology. 2010; 24: 1312–16. doi: 10.1111/j.1468-3083.2010.03638.

Tamega AA, Miot HA, Moco NP, Silva MG, Marques ME, Miot LD. Gene and protein expression of oestrogen-b and progesterone receptors in facial melasma and adjacent healthy skin in women. International Journal of Cosmetic Science. 2015; 37: 222–28. doi: 10.1111/ics.12186

Wiedemann C, Neagele U, Schramm G, Berking C. Inhibitory effects of progestogens on the estrogen stimulation of melanocytes in vitro. Elsevier. 2009; 80: 292–98.

KrupaShankar DSR, Somani VK, Kohli M, Sharad J, Ganjoo A, Kandhari S, Mysore VR et al.. A Cross-Sectional, Multicentric Clinico-Epidemiological Study of Melasma in India. Dermatol Ther (Heidelb). 2014; 4:71–81. doi : 10.1007/s13555-014-0046-1

Jagannathan M, Sadagopan K, Ekkarakudy J, Anandan H. Clinico-epidemiological Study of Patients with Melasma in a Tertiary Care Hospital - A Prospective Study. International Journal of Scientifi c Study. 2017; 4 : 117-20. doi : 10.17354/ijss/2017/61

Pawar S, Khatu S, Gokhale N. A Clinico-Epidemiological Study of Melasma in Pune Patients. Journal of Pigmentary Disorders 2015, 2:11. .doi.org/10.4172/2376-0427.1000219

Reddy AJ, Kumar P, Sawant SR, Jain SK. Endocrinological Evaluation of Melasma in Females of Western Uttar Pradesh Region. International Journal of Scientific Study. 2014 ; vol 2 (6).

Manjunath KG, Kiran C, Sonakshi S, Ashwini N, Agrawal R. Comparative Study of Wood’s Lamp and Dermoscopic Features of Melasma. J Evid Based Med healthc. 2015: 2(60); 9012-15. doi: 10.18410


No Supplementary Material available for this article.
Article Views      : 0
PDF Downloads : 0